🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Thomas Denize

Harvard University

ORCID: 0000-0002-8618-7691

Also affiliated with Massachusetts General Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 5%percentile
0.481Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma

Histopathology(2023)10.1111/his.15034
Top 40%
0.481DataRank
Top 40%9 citations

Catherine B. Meador, Anna B Rider, Maria Ganci, Jaimie L. Barth, Marina Kem +3 more

Papers

Driven by 14 papers — median percentile 60. Top paper: “Progressive immune dysfunction with advancing disease stage in renal cell carcinoma”.

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

Cancer Cell(2021)10.1016/j.ccell.2021.02.013
N/A
9.5DataRank · unranked
526 citations

Kelly Street, Kelly P. Burke, David L. Cookmeyer, Thomas Denize, Christina B. Pedersen +30 more

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Cancer Cell(2021)10.1016/j.ccell.2021.02.015
N/A
0.964DataRank · unranked
617 citations

Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Jingyi Wu +26 more

Concordance of ASCL1, NEUROD1 and POU2F3 transcription factor‐based subtype assignment in paired tumour samples from small cell lung carcinoma

Histopathology(2023)10.1111/his.15034
Top 40%
0.481DataRank
Top 40%9 citations

Catherine B. Meador, Anna B Rider, Maria Ganci, Jaimie L. Barth, Marina Kem +3 more

Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma

Cancer Cell(2025)10.1016/j.ccell.2025.05.009
N/A
0.330DataRank · unranked
8 citations

Meng Xiao He, Ziad Bakouny, Abhay Kanodia, Sara Napolitano, Jingyi Wu +25 more

KDM6A epigenetically regulates subtype plasticity in small cell lung cancer

Nature Cell Biology(2023)10.1038/s41556-023-01210-z
N/A
0DataRank · unranked
69 citations

Yixiang Li, Matthew A. Booker, Yingtian Xie, Sarah Naomi Olsen, Radhika A. Patel +19 more

Spatially aware deep learning reveals tumor heterogeneity patterns that encode distinct kidney cancer states

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101189
N/A
0DataRank · unranked
39 citations

Thomas Denize, Ziad Bakouny, Chris Labaki, Breanna M. Titchen, Kevin Bi +13 more

PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-2274
N/A
0DataRank · unranked
37 citations

Opeyemi A. Jegede, Sayed Matar, Nourhan El Ahmar, Destiny J. West, Emily Walton +16 more

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma

Nature Communications(2023)10.1038/s41467-023-35833-5
N/A
0DataRank · unranked
34 citations

Sarah Abou Alaiwi, Sylvan C. Baca, Elio Adib, Rosario I. Corona, Ji-Heui Seo +31 more

A pathology foundation model for cancer diagnosis and prognosis prediction

Nature(2024)10.1038/s41586-024-07894-z
N/A
0DataRank · unranked
457 citations

Junhan Zhao, Eliana Marostica, Wei Yuan, Jietian Jin, Jiayu Zhang +24 more

Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma

Cancer Discovery(2025)10.1158/2159-8290.cd-24-0991
N/A
0DataRank · unranked
38 citations

Lena V. Wirth, Kelly Street, Neil Ruthen, Opeyemi A. Jegede, Nicholas R. Schindler +22 more

Presence of tertiary lymphoid structures and exhausted tissue-resident T cells determines clinical response to PD-1 blockade in renal cell carcinoma 3574

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1362
N/A
0DataRank · unranked
0 citations

Miya B. Hugaboom, Kelly Street, Neil Ruthen, Opeyemi A. Jegede, Nicholas R. Schindler +22 more

Regulation of Neuroendocrine Plasticity by the RNA-Binding Protein ZFP36L1

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.22.465501
N/A
0DataRank · unranked
4 citations

Yavuz T. Durmaz, Yixiang Li, Amin H. Sabet, Amir Vajdi, Thomas Denize +11 more

Integrative clinical and molecular characterization of translocation renal cell carcinoma

Cell Reports(2022)10.1016/j.celrep.2021.110190
N/A
0DataRank · unranked
118 citations

Ananthan Sadagopan, Praful Ravi, Nebiyou Y. Metaferia, Jiao Li, Shatha AbuHammad +35 more

Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1

Nature Communications(2022)10.1038/s41467-022-31998-7
N/A
0DataRank · unranked
42 citations

Yavuz T. Durmaz, Yixiang Li, Amin H. Sabet, Amir Vajdi, Thomas Denize +12 more